Skip to content

Morphological Changes of Upper Trapezius Muscle After Physotherapy in Oral Cancer

Ultrasonographic Assessment of Upper Trapezius Mmorphological Changes in Oral Cancer Patients With Scapular Dyskinesis: An Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07166575
Enrollment
10
Registered
2025-09-10
Start date
2025-10-16
Completion date
2027-12-31
Last updated
2026-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Cancer

Keywords

Ultrasonography, Upper Trapezius, Shoulder, Oral Cancer

Brief summary

The study aims to evaluate the morphological changes of upper trapezius muscle, using B-mode ultrasonography, in patients with oral cancer undergone neck dissection and physiotherapy. It also investigates the relationship between morphological changes and shoulder active range of motion in abduction. Furthermore , the study assesses the potential of B-mode ultrasonography as an objective tool for monitoring outcomes of the rehabilitation in this population.

Detailed description

The study aims to investigate the effect of 8-week physiotherapy on morphological change of upper trapezius muscle in oral cancer patients who have undergone neck dissection. Key outcome measurements include the muscle's thickness and cross-sectional area (CSA), measured via B-mode ultrasonography, as well as the active range of motion (AROM) in shoulder abduction. Neck dissections may result in spinal accessory nerve (CN XI) injury, often leading to shoulder pain, upper trapezius weakness and impaired shoulder mobility. Therefore, understanding the relationship between muscle thickness, CSA, and AROM is important. The study's goal is to explore the correlation between muscle morphological changes and functional outcomes, and further evaluate the role of B-mode ultrasonography as a non-invasive tool in monitoring muscle morphology in shoulder rehabilitation progress with post-surgical oral cancer patients with shoulder dysfunction.

Interventions

DIAGNOSTIC_TESTB-mode ultrasonography

Thickness and cross-sectional area of upper trapezius muscle

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Newly diagnosed oral cancer patients with scapular dyskinesis, who have undergone neck dissections within 3 months * Able to cooperate with assessments and physical therapy, and capable of understanding and signing the informed consent form. * Age between 20 and 65 years.

Exclusion criteria

* Unable to effectively communicate. * Diagnosed with conditions affecting motor function.

Design outcomes

Primary

MeasureTime frameDescription
Cross-sectional area of upper trapezius musclePre-intervention, 8 weeks post-interventionCSA of the upper trapezius muscle is measured via B-mode panoramic ultrasonography. Panoramic B-mode ultrasonography will be performed by placing the probe at the spinous process of the fourth cervical vertebra (C4) and moving it laterally toward the posterior margin of the sternocleidomastoid muscle.
Thickness of upper trapezius musclePre-intervention, 8 weeks post-interventionThickness of upper trapezius muscle is measured via B-mode ultrasonography. The ultrasound probe will be positioned at the midpoint between the spinous process of the seventh cervical vertebra (C7) and the acromion, aligned parallel to the muscle fibers.
Active range of motion in shoulder abductionPre-intervention, 8 weeks post-interventionAROM in shoulder abduction is measured by a goniometer, with the fulcrum positioned over the anterior aspect of the acromial process. The proximal arm is aligned parallel to the midline of the anterior aspect of the sternum, while the distal arm is aligned with the anterior midline of the humerus.

Countries

Taiwan

Contacts

CONTACTYueh-Hsia Chen, PhD
yuehhsiachen@ntu.edu.tw+886-2-33668133
PRINCIPAL_INVESTIGATORYueh-Hsia Chen, PhD

National Taiwan University, College of Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 22, 2026